Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: Measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation

Through a multidisciplinary approach involving experimental and computational studies, we address quantitative aspects of signaling mechanisms triggered in the cell by the receptor targets of hallucinogenic drugs, the serotonin 5-HT2A receptors. To reveal the properties of the signaling pathways, and the way in which responses elicited through these receptors alone and in combination with other serotonin receptors' subtypes (the 5-HT1AR), we developed a detailed mathematical model of receptor-mediated ERK1/2 activation in cells expressing the 5-HT1A and 5-HT2A subtypes individually, and together. In parallel, we measured experimentally the activation of ERK1/2 by the action of selective agonists on these receptors expressed in HEK293 cells. We show here that the 5-HT1AR agonist Xaliproden HCl elicited transient activation of ERK1/2 by phosphorylation, whereas 5-HT2AR activation by TCB-2 led to higher, and more sustained responses. The 5-HT2AR response dominated the MAPK signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist Ketanserin could not be rescued by the 5-HT1AR agonist. Computational simulations produced qualitative results in good agreement with these experimental data, and parameter optimization made this agreement quantitative. In silico simulation experiments suggest that the deletion of the positive regulators PKC in the 5-HT2AR pathway, or PLA2 in the combined 5-HT1A/2AR model greatly decreased the basal level of active ERK1/2. Deletion of negative regulators of MKP and PP2A in 5-HT1AR and 5-HT2AR models was found to have even stronger effects. Under various parameter sets, simulation results implied that the extent of constitutive activity in a particular tissue and the specific drug efficacy properties may determine the distinct dynamics of the 5-HT receptor-mediated ERK1/2 activation pathways. Thus, the mathematical models are useful exploratory tools in the ongoing efforts to establish a mechanistic understanding and an experimentally testable representation of hallucinogen-specific signaling in the cellular machinery, and can be refined with quantitative, function-related information.

[1]  Probal Banerjee,et al.  Agonist Stimulation of the Serotonin1A Receptor Causes Suppression of Anoxia‐Induced Apoptosis via Mitogen‐Activated Protein Kinase in Neuronal HN2‐5 Cells , 1999, Journal of neurochemistry.

[2]  D. Teis,et al.  Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. , 2002, Developmental cell.

[3]  B. Kholodenko,et al.  Quantification of information transfer via cellular signal transduction pathways , 1997, FEBS letters.

[4]  Chi-Ying F. Huang,et al.  Ultrasensitivity in the mitogen-activated protein kinase cascade. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  E. Nishida,et al.  Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway , 2002, Nature Cell Biology.

[6]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[7]  Douglas A. Lauffenburger,et al.  Erratum: Bioengineering and systems biology (Annals of Biomedical Engigeering (2006) DOI: 10.1007/s10439-005-9047-7) , 2006 .

[8]  R. Lefkowitz,et al.  Ras-dependent Mitogen-activated Protein Kinase Activation by G Protein-coupled Receptors , 1997, The Journal of Biological Chemistry.

[9]  G. Rubin,et al.  KSR modulates signal propagation within the MAPK cascade. , 1996, Genes & development.

[10]  P. Hawkins,et al.  Activation of phosphatidylinositol 4,5-bisphosphate supply by agonists and non-hydrolysable GTP analogues. , 1993, The Biochemical journal.

[11]  Edda Klipp,et al.  Systems Biology , 1994 .

[12]  Gregory Bock,et al.  'In silico' simulation of biological processes , 2002 .

[13]  P. Albert,et al.  Cell-specific signaling of the 5-HT1A receptor. Modulation by protein kinases C and A. , 1991, Journal of Biological Chemistry.

[14]  J. Axelrod,et al.  Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Xavier Deupi,et al.  Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.

[16]  Stuart C. Sealfon,et al.  Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior , 2007, Neuron.

[17]  P. Leff,et al.  The two-state model of receptor activation. , 1995, Trends in pharmacological sciences.

[18]  Shinya Kuroda,et al.  Prediction and validation of the distinct dynamics of transient and sustained ERK activation , 2005, Nature Cell Biology.

[19]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[20]  J. Launay,et al.  Cross-talk between 5-Hydroxytryptamine Receptors in a Serotonergic Cell Line , 1998, The Journal of Biological Chemistry.

[21]  George Khelashvili,et al.  Protein Diffusion on Charged Membranes: A Dynamic Mean-Field Model Describes Time Evolution and Lipid Reorganization , 2007, Biophysical journal.

[22]  D. Johnston,et al.  Protein Kinase Modulation of Dendritic K+ Channels in Hippocampus Involves a Mitogen-Activated Protein Kinase Pathway , 2002, The Journal of Neuroscience.

[23]  Reinhart Heinrich,et al.  Mathematical models of protein kinase signal transduction. , 2002, Molecular cell.

[24]  E. Nishida,et al.  Sef is a spatial regulator for Ras/MAP kinase signaling. , 2004, Developmental cell.

[25]  Douglas A. Lauffenburger,et al.  Bioengineering and Systems Biology , 2006, Annals of Biomedical Engineering.

[26]  L. Loew,et al.  Quantitative cell biology with the Virtual Cell. , 2003, Trends in cell biology.

[27]  Yun-Wei Lin,et al.  Cooperation of ERK and SCFSkp2 for MKP-1 Destruction Provides a Positive Feedback Regulation of Proliferating Signaling* , 2006, Journal of Biological Chemistry.

[28]  S. Endo,et al.  ERKs regulate PKC-dependent synaptic depression and declustering of glutamate receptors in cerebellar Purkinje cells , 2003, Neuropharmacology.

[29]  J. Stiles,et al.  Spatial Distribution of Calcium Entry Evoked by Single Action Potentials within the Presynaptic Active Zone , 2004, The Journal of Neuroscience.

[30]  Marta Filizola,et al.  Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Barbara Hausmann,et al.  Signaling Life and Death in the Thymus: Timing Is Everything , 2003, Science.

[32]  A. Gilman,et al.  G proteins: transducers of receptor-generated signals. , 1987, Annual review of biochemistry.

[33]  Burton S. Rosner,et al.  Neuropharmacology , 1958, Nature.

[34]  Marta Filizola,et al.  Modeling activated states of GPCRs: the rhodopsin template , 2007, J. Comput. Aided Mol. Des..

[35]  D. Hoyer,et al.  Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

[36]  S. Watts,et al.  Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059. , 1996, The Journal of pharmacology and experimental therapeutics.

[37]  Robert E. Lewis,et al.  Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP , 2004, Nature.

[38]  B. Kholodenko.  Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.

[39]  Alan Wells,et al.  Modeling of signal-response cascades using decision tree analysis , 2005, Bioinform..

[40]  M. Rosner,et al.  Histamine Antagonizes Serotonin and Growth Factor-induced Mitogen-activated Protein Kinase Activation in Bovine Tracheal Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[41]  E. Formstecher,et al.  PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. , 2001, Developmental cell.

[42]  Xavier Deupi,et al.  Activation of G protein-coupled receptors. , 2007, Advances in protein chemistry.

[43]  D. S. Cowen,et al.  Enhanced activation of Akt and extracellular‐regulated kinase pathways by simultaneous occupancy of Gq‐coupled 5‐HT2A receptors and Gs‐coupled 5‐HT7A receptors in PC12 cells , 2005, Journal of neurochemistry.

[44]  Ravi Iyengar,et al.  Quantitative Information Management for the Biochemical Computation of Cellular Networks , 2004, Science's STKE.

[45]  E. Wimmer,et al.  MAP Kinase Phosphatase As a Locus of Flexibility in a Mitogen-Activated Protein Kinase Signaling Network , 2022 .

[46]  R. Lefkowitz,et al.  Serotonin 5-HT1A Receptor-mediated Erk Activation Requires Calcium/Calmodulin-dependent Receptor Endocytosis* , 1999, The Journal of Biological Chemistry.

[47]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[48]  S. Maayani,et al.  5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism. , 1996, Molecular pharmacology.

[49]  Christopher R. Myers,et al.  Universally Sloppy Parameter Sensitivities in Systems Biology Models , 2007, PLoS Comput. Biol..

[50]  Marta Filizola,et al.  Dynamic models of G-protein coupled receptor dimers: indications of asymmetry in the rhodopsin dimer from molecular dynamics simulations in a POPC bilayer , 2006, J. Comput. Aided Mol. Des..

[51]  Yun-Wei Lin,et al.  ERK1/2 Achieves Sustained Activation by Stimulating MAPK Phosphatase-1 Degradation via the Ubiquitin-Proteasome Pathway* , 2003, Journal of Biological Chemistry.

[52]  R. Miledi,et al.  Efficient coupling of 5-HT1a receptors to the phospholipase C pathway in Xenopus oocytes. , 1997, Brain research. Molecular brain research.

[53]  H. Weinstein,et al.  Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy. , 2003, Molecular Pharmacology.

[54]  S. Sealfon,et al.  Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex , 2003, The Journal of Neuroscience.

[55]  Harel Weinstein,et al.  Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors , 2005, The AAPS Journal.

[56]  D. Lauffenburger,et al.  Applying computational modeling to drug discovery and development. , 2006, Drug discovery today.

[57]  Bernhard Ø. Palsson.  Systems Biology: Epilogue , 2006 .

[58]  R. Nicoll,et al.  Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. , 1987, The Journal of physiology.

[59]  Graeme Milligan,et al.  Identification of a serotonin/glutamate receptor complex implicated in psychosis , 2008, Nature.

[60]  Prahlad T. Ram,et al.  MAP Kinase Phosphatase As a Locus of Flexibility in a Mitogen-Activated Protein Kinase Signaling Network , 2002, Science.

[61]  Michael R. Braden,et al.  1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists. , 2006, Journal of medicinal chemistry.

[62]  E. sanders-Bush,et al.  Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors , 2002, Neuroscience.

[63]  H. Weinstein,et al.  Molecular Determinants for the Complex Binding Specificity of the PDZ Domain in PICK1* , 2005, Journal of Biological Chemistry.

[64]  D. Morrison,et al.  KSR: a MAPK scaffold of the Ras pathway? , 2001, Journal of cell science.

[65]  H. Weinstein,et al.  Active State-like Conformational Elements in the β2-AR and a Photoactivated Intermediate of Rhodopsin Identified by Dynamic Properties of GPCRs† , 2008, Biochemistry.

[66]  Roland Eils,et al.  Computational Systems Biology , 2006 .

[67]  J. Sweatt,et al.  Molecular psychology: roles for the ERK MAP kinase cascade in memory. , 2002, Annual review of pharmacology and toxicology.

[68]  T. Reader,et al.  The human 5-HT1A receptor: comparison of its binding properties in transfected cells and cortical tissue. , 1997, General pharmacology.

[69]  Arthur Christopoulos,et al.  Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.

[70]  G. Aghajanian,et al.  Serotonin and Hallucinogens , 1999, Neuropsychopharmacology.

[71]  B. Roth,et al.  High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model. , 1997, The Journal of pharmacology and experimental therapeutics.

[72]  Leslie M Loew,et al.  Computational cell biology: spatiotemporal simulation of cellular events. , 2002, Annual review of biophysics and biomolecular structure.

[73]  B. Kholodenko,et al.  Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. , 2000, European journal of biochemistry.

[74]  H. Sauro,et al.  Quantitative analysis of signaling networks. , 2004, Progress in biophysics and molecular biology.

[75]  D. Lauffenburger,et al.  Computational modelling of ErbB family phosphorylation dynamics in response to transforming growth factor alpha and heregulin indicates spatial compartmentation of phosphatase activity. , 2006, Systems biology.

[76]  D. Lauffenburger,et al.  A Systems Model of Signaling Identifies a Molecular Basis Set for Cytokine-Induced Apoptosis , 2005, Science.

[77]  J. Bockaert,et al.  Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis. , 1992, Molecular biology of the cell.